THE NEW QUESTIONNAIRE «THERAPY ADHERENCE FACTOR SCALE»
- Authors: Isakov V.A1, Kholkina A.A1, Zinkevich E.R1
-
Affiliations:
- Saint Petersburg State Pediatric Medical University
- Issue: Vol 31, No 3 (2020)
- Pages: 46-50
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/114192
- DOI: https://doi.org/10.29296/25877305-2020-03-10
- ID: 114192
Cite item
Open Access
Access granted
Abstract
High compliance is considered as one of the most important conditions for the efficiency of treatment. Confirmation of this can be seen by practitioners when using inpatients on an example; compensation for symptoms or recovery of the patient can be fully achieved by the healthcare staffs monitoring of medical prescriptions under these conditions. Timely and adequate determination of the level of patient compliance will help to develop an effective treatment strategy for the period when the patient leaves the healthcare facility and is face-to-face with his/her diseases, which is especially important for patients with chronic diseases. Despite a certain abundance of indirect methods for diagnosing adherence to treatment, there are currently no methods for assessing factors influencing compliance. The designed questionnaire «Therapy adherence factor scale» used in patients who had undergone emergency intervention into the coronary arteries demonstrated satisfactory psychometric characteristics. Its use will assist investigators and practitioners to determine the factors that influence treatment adherence.
Full Text
About the authors
V. A Isakov
Saint Petersburg State Pediatric Medical UniversityCandidate of Medical Sciences
A. A Kholkina
Saint Petersburg State Pediatric Medical University
Email: aleksandra.kholkina1@gmail.com
E. R Zinkevich
Saint Petersburg State Pediatric Medical UniversityCandidate of Pedagogical Sciences
References
- Haynes R., Taylor D., Sackett D. Compliance in Health Care / Baltimore, MD: The Johns Hopkins University Press, 1979; pp. 1-2.
- Royal Pharmaceutical Society of Great Britain. From Compliance to Concordance: Achieving Shared Goals in Medicine Taking / London: Royal Pharmaceutical Society, in partnership with Merck Sharp & Dohme, 1997; p. 55.
- Vrijens B., DeGeest S. A new taxonomy for describing and defining adherence to medications // Br. J. Clin. Pharmacol. - 2012; 73 (5): 691-705. doi: 10.1111/j.1365-2125.2012.04167.x.
- Hahn S., Park J., Skinner E. et al. Development of the ASK-20 adherence barrier survey // Curr. Med. Res. Opin. - 2008; 24 (7): 2127-38. doi: 10.1185/03007990802174769.
- Thompson K., Kulkarni J., Sergejew A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. // Schizophr. Res. - 2000; 42 (3): 241-7. doi: 10.1016/S0920-9964(99)00130-9.
- Kim M., Hill M., Bone L. et al. Development and testing of the Hill-Bone Compliance to High Blood PressureTherapy Scale // Prog. Cardiovasc. Nurs. -2000; 15 (3): 90-6. doi: 10.1111/j.1751-7117.2000.tb00211.x.
- Morisky D., Green L., Levine D. Concurrent and predictive validity of a selfreported measure of medication adherence // Medical Care. - 1986; 24 (1): 67-74. doi: 10.1097/00005650-198601000-00007.
- Morisky D., Ang A., Krousel-Wood M. et al. Predictive validity of a medication adherence measure in an outpatient setting // J. Clin. Hypertens. (Greenwich) - 2008; 10 (5): 348-54. doi: 10.1111/j.1751-7176.2008.07572.x.
- Kisa A., Sabaté E., Nuflo-Solinis R. Adherence to long-term therapies: evidence for action / Genève: Organisation mondiale de la Santé WHO, 2003; p. 198.
- Bjelland I., Dahl A., Haug T. et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. // J. Psychosom. Res. - 2002; 52 (2): 69-77. DOI: S0022-3999(01)00296-3.
- Лукина Ю.В., Кутишенко Н.П., Марцевич С.Ю. Приверженность лечению: современный взгляд на знакомую проблему // Кардиоваск. тер. и профилакт. - 2017; 16 (1): 91-5 doi: 10.15829/17288800-2017-1-91-95.
- Налетов А.В., Вьюниченко Ю.С., Масюта Д.И. Родительская комплаентность и влияющие на нее факторы при лечении детей с синдромом раздраженного кишечника // Педиатр. - 2018; 9 (2): 67-70 doi: 10.17816/PED9267-70.
- Налетов А.В., Налетов С.В., Баринова А.С. и др. Эффективность антихеликобактерной терапии в лечении хронической гастродуоденальной патологии у детей при различных уровнях комплаентности // Педиатр. -2018; 9 (4): 81-6 DOI: 10.17816/ PED9481-86.
- Холкина А.А., Исаков В.А. Оценка приверженности лечению больных с метаболическим синдромом после вмешательства на коронарных артериях с помощью модифицированного опросника MMAS-8. Мат-лы VIII Росс. научно-практ. конгр. «Метаболический синдром. Фундаментальные и клинические аспекты - от теории к практике», 2018; с. 31-2
Supplementary files
